Russell Investments Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,386
Closed -$6.89K 4151
2025
Q2
$6.89K Buy
1,386
+1,278
+1,183% +$5.72K ﹤0.01% 3397
2025
Q1
$527 Buy
+108
New +$649 ﹤0.01% 3668
2024
Q4
Sell
-16
Closed -$169 3704
2024
Q3
$169 Sell
16
-665
-98% -$11.1K ﹤0.01% 3652
2024
Q2
$13.4K Buy
+681
New +$13.6K ﹤0.01% 3018
2024
Q1
Sell
-4,230
Closed -$117K 3309
2023
Q4
$117K Sell
4,230
-699
-14% -$42.6K ﹤0.01% 2532
2023
Q3
$300K Sell
4,929
-29
-0.6% -$2.04K ﹤0.01% 2388
2023
Q2
$326K Buy
4,958
+15
+0.3% +$1.1K ﹤0.01% 2354
2023
Q1
$314K Buy
4,943
+1,716
+53% +$196K ﹤0.01% 2386
2022
Q4
$447K Buy
3,227
+2,236
+226% +$315K ﹤0.01% 2328
2022
Q3
$123K Sell
991
-181
-15% -$20.5K ﹤0.01% 2635
2022
Q2
$96K Sell
1,172
-2,376
-67% -$184K ﹤0.01% 2669
2022
Q1
$342K Sell
3,548
-1,021
-22% -$135K ﹤0.01% 2335
2021
Q4
$912K Sell
4,569
-4,958
-52% -$1.17M ﹤0.01% 2188
2021
Q3
$2.36M Sell
9,527
-719
-7% -$206K ﹤0.01% 1737
2021
Q2
$4.24M Sell
10,246
-8,301
-45% -$3.29M 0.01% 1453
2021
Q1
$7.24M Buy
18,547
+1,546
+9% +$761K 0.01% 1152
2020
Q4
$9.54M Buy
17,001
+2,222
+15% +$1.41M 0.02% 882
2020
Q3
$10.3M Buy
14,779
+3,410
+30% +$2.66M 0.02% 750
2020
Q2
$8.98M Buy
11,369
+6,398
+129% +$4.82M 0.02% 786
2020
Q1
$2.96M Buy
4,971
+3,946
+385% +$3.85M 0.01% 1255
2019
Q4
$1.16M Sell
1,025
-752
-42% -$817K ﹤0.01% 2031
2019
Q3
$2.11M Buy
1,777
+439
+33% +$670K ﹤0.01% 1657
2019
Q2
$2.21M Sell
1,338
-364
-21% -$630K ﹤0.01% 1625
2019
Q1
$3.47M Buy
1,702
+182
+12% +$320K 0.01% 1433
2018
Q4
$1.95M Buy
1,520
+1,294
+573% +$1.98M ﹤0.01% 1627
2018
Q3
$427K Sell
226
-1,208
-84% -$2.5M ﹤0.01% 2456
2018
Q2
$2.92M Sell
1,434
-344
-19% -$784K 0.01% 1556
2018
Q1
$3.93M Sell
1,778
-154
-8% -$392K 0.01% 1489
2017
Q4
$4.5M Sell
1,932
-975
-34% -$1.98M 0.01% 1405
2017
Q3
$5.17M Sell
2,907
-95
-3% -$133K 0.01% 1253
2017
Q2
$4.08M Buy
3,002
+391
+15% +$472K 0.01% 1338
2017
Q1
$3.07M Buy
2,611
+774
+42% +$789K 0.01% 1500
2016
Q4
$1.48M Buy
+1,837
New +$1.46M ﹤0.01% 1976

Russell Investments Group's BLUE Position: Q3 2025 in Review

Russell Investments Group sold out of bluebird bio (BLUE) in Q3 2025, closing a stake of 1,386 shares — an estimated $6.89K sold.

Russell Investments Group first reported a position in BLUE in Q4 2016 and held it in 33 quarters. The position peaked at $10.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold BLUE as of Q3 2025.

  • Russell Investments Group reported no remaining bluebird bio position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 1,386 bluebird bio shares in Q3 2025, an estimated $6.89K.
  • Russell Investments Group first reported a position in bluebird bio in Q4 2016 and held it in 33 quarters.
  • Russell Investments Group's bluebird bio position peaked at $10.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held bluebird bio as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.